Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07682207
Recruiting
Accelerated iTBS for PTSD and Depression
Not applicable · Canada · 1 site
Registry update: 18 Sept 2026
NCT07789106
Recruiting
A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists
Not applicable · United Kingdom · 1 site
Registry update: 19 Oct 2026
NCT07829081
Recruiting
Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
Not applicable · Switzerland · 3 sites
Registry update: 18 Sept 2026
NCT07786883
Recruiting
Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case Design
Not applicable · Netherlands · 1 site
Registry update: 26 Aug 2026
NCT06899178
Recruiting
Atomoxetine in Melanocortin Obesity Syndrome
Phase 2 · United States · 3 sites
Registry update: 7 Aug 2026
NCT07282678
Recruiting
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
NCT07754474
Recruiting
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity
Phase 1 · Germany · 1 site
Registry update: 23 Sept 2026
NCT07389005
Recruiting
Exercise, Chronotype, and Prediabetes
Not applicable · Germany · 1 site
Registry update: 11 Sept 2026
NCT07691281
Recruiting
Disparities in Mental Health Screening and Support
Not applicable · Italy · 1 site
Registry update: 10 Sept 2026
NCT07104916
Recruiting
Mindfulness-based Psilocybin Therapy for PTSD
Phase 2 · United States · 1 site
Registry update: 19 Oct 2026
NCT07637578
Recruiting
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
Phase 2 · United States · 6 sites
Registry update: 4 Sept 2026
NCT07788118
Recruiting
A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Phase 1/2 · China · 1 site
Registry update: 26 Aug 2026
NCT07439042
Recruiting
Buspirone for Anxiety in Autistic Youth
Phase 4 · United States · 1 site
Registry update: 17 Sept 2026
NCT07718854
Recruiting
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
Phase 2 · United States · 1 site
Registry update: 16 Sept 2026
NCT07587242
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
Phase 3 · Australia, Belgium, Germany, Spain, France, United Kingdom, Italy, Netherlands · 18 sites
Registry update: 13 Oct 2026
NCT07624305
Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Phase 3 · Argentina, Austria, Bulgaria, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Greece, India, Italy, Japan, South Korea, Mexico, Malaysia, Peru, Philippines, Poland, Romania, Thailand, Taiwan, Ukraine, United States, Vietnam · 374 sites
Registry update: 24 Sept 2026
NCT07802080
Recruiting
Effects of Kettlebell Swing Training Combined With Breathing Exercises on Respiratory Muscle Strength and Pulmonary Function in Overweight and Obese Young Adults
Not applicable · Thailand · 1 site
Registry update: 3 Sept 2026
NCT07831304
Recruiting
Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic Coronary Syndrome
Not applicable · Italy · 1 site
Registry update: 6 Nov 2026
NCT07806604
Recruiting
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
Not applicable · China · 2 sites
Registry update: 8 Sept 2026
NCT07619599
Recruiting
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
Phase 1 · United States · 1 site
Registry update: 19 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.